Sign in
4

Changes in Ownership

Dyne Therapeutics, Inc. Filed Acc 0001193125-26-277529

Director sold 84,355 shares at an average $20.10 ($1,695,689)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Kersten Dirk Director 2026-06-17 Sale 10b5-1 −37,454 $20.14 $754,316 4,159,119 I: show line 1 in the form
Kersten Dirk Director 2026-06-18 Sale 10b5-1 −46,901 $20.07 $941,373 4,112,218 I: show line 2 in the form
Open-market sales · 84,355 sh · avg $20.10 · $1,695,689
Loading xslF345X06/ownership.xml…